Impact of the timing of triple intrathec
โ
Hvizdala, Eva ;Berry, D. H. ;Chen, Timothy ;Dyment, Paul G. ;Kim, Tae H. ;Steube
๐
Article
๐
1984
๐
John Wiley and Sons
๐
English
โ 446 KB
Five weekly doses of triple intrathecal (IT) chemotherapy (methotrexate, hydrocortisone, cytosine arabinoside) starting on day 1 of treatment were added to systemic induction therapy in a regimen (Arm 3) that was compared to three other regimens (Arms 1, 2, and 4) in which central nervous system (CN